A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
Intensive combined therapy including modification of the lifestyle, intake of metformin and/or sulfonylureas, insulin treatment in the absence ofadequate HbAc1 control, hypolipidemic, early antihypertensive and antithrombotic therapy not only decreases the frequency of DM2 complicationsbut also redu...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2011-06-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5647 |
| _version_ | 1797255253487255552 |
|---|---|
| author | Yury Shavkatovich Khalimov Alla Vsevolodovna Rudakova |
| author_facet | Yury Shavkatovich Khalimov Alla Vsevolodovna Rudakova |
| author_sort | Yury Shavkatovich Khalimov |
| collection | DOAJ |
| description | Intensive combined therapy including modification of the lifestyle, intake of metformin and/or sulfonylureas, insulin treatment in the absence ofadequate HbAc1 control, hypolipidemic, early antihypertensive and antithrombotic therapy not only decreases the frequency of DM2 complicationsbut also reduces the total cost of the treatment (1.8 times compared with traditional therapy). Reduction in cardiovascular mortality achieved inSTENO-2 was due to intense control of risk factors at early stages of therapy with the use of modified release gliclazide (Diabeton MV). This treatmentis considered to be not only more efficacious than routine therapy but also to significantly reduce the cost of the management of DM2 |
| first_indexed | 2024-03-08T15:21:59Z |
| format | Article |
| id | doaj.art-054ce88c5fff4e6dadc21c6fbb38b1e6 |
| institution | Directory Open Access Journal |
| issn | 2072-0351 2072-0378 |
| language | English |
| last_indexed | 2024-04-24T22:02:55Z |
| publishDate | 2011-06-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj.art-054ce88c5fff4e6dadc21c6fbb38b1e62024-03-20T11:47:56ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782011-06-0114211612010.14341/2072-0351-56475605A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)Yury Shavkatovich Khalimov0Alla Vsevolodovna Rudakova1S.M.Kirov Military Medical Academy, Sankt-PeterburgState Chemico-Pharmaceutical Academy, Sankt-PeterburgIntensive combined therapy including modification of the lifestyle, intake of metformin and/or sulfonylureas, insulin treatment in the absence ofadequate HbAc1 control, hypolipidemic, early antihypertensive and antithrombotic therapy not only decreases the frequency of DM2 complicationsbut also reduces the total cost of the treatment (1.8 times compared with traditional therapy). Reduction in cardiovascular mortality achieved inSTENO-2 was due to intense control of risk factors at early stages of therapy with the use of modified release gliclazide (Diabeton MV). This treatmentis considered to be not only more efficacious than routine therapy but also to significantly reduce the cost of the management of DM2https://www.dia-endojournals.ru/jour/article/view/5647steno-2diabetes mellitussteno-2gliclazide |
| spellingShingle | Yury Shavkatovich Khalimov Alla Vsevolodovna Rudakova A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study) Сахарный диабет steno-2 diabetes mellitus steno-2 gliclazide |
| title | A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study) |
| title_full | A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study) |
| title_fullStr | A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study) |
| title_full_unstemmed | A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study) |
| title_short | A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study) |
| title_sort | cost effectiveness analysis of intensive therapy of type 2 diabetes mellitus results of steno 2 study |
| topic | steno-2 diabetes mellitus steno-2 gliclazide |
| url | https://www.dia-endojournals.ru/jour/article/view/5647 |
| work_keys_str_mv | AT yuryshavkatovichkhalimov acosteffectivenessanalysisofintensivetherapyoftype2diabetesmellitusresultsofsteno2study AT allavsevolodovnarudakova acosteffectivenessanalysisofintensivetherapyoftype2diabetesmellitusresultsofsteno2study AT yuryshavkatovichkhalimov costeffectivenessanalysisofintensivetherapyoftype2diabetesmellitusresultsofsteno2study AT allavsevolodovnarudakova costeffectivenessanalysisofintensivetherapyoftype2diabetesmellitusresultsofsteno2study |